View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
July 27, 2011

Dr Reddy’s Signs Memorandum of Understanding with Fujifilm for Generic Drug Venture

Fujifilm Corporation and Dr Reddy's Laboratories have signed a memorandum of understanding to develop generic drugs in Japan. The joint venture will manufacture and promote generic drugs using Fujifilm's quality control technologies and Dr Reddy's knowledge in the pharmaceutical sector.

By cms admin

Fujifilm Corporation and Dr Reddy’s Laboratories have signed a memorandum of understanding to develop generic drugs in Japan.

The joint venture will manufacture and promote generic drugs using Fujifilm’s quality control technologies and Dr Reddy’s knowledge in the pharmaceutical sector.

Dr Reddy will hold a 51% stake and Fujifilm will gain a 49% interest in the company, which intends to launch its first products in Japan in the next three to four years.

Fujifilm president and CEO Shigetaka Komori said, “With the execution of the memorandum of understanding with D. Reddy’s Laboratories, Fujifilm will have excellent capability in developing and manufacturing across active pharmaceutical ingredients and formulations of generic drugs.”

Dr Reddy CEO and vice-chairman GV Prasad added, “We are confident that Fujifilm’s advanced R&D capabilities, backed by Dr. Reddy’s high-quality generic drug development, will help the joint venture establish a strong presence in the Japanese pharmaceutical market. Our planned entry into Japan underscores our commitment to bring affordable and innovative drugs to more patients worldwide.”

The government of Japan actively promotes the use of generics and hopes to increase the market share of generic drugs by sales volume to at least 30% by 2012.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology